Ionis Pharmaceuticals IONS Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's payments to acquire property, plant, and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's payments to acquire property, plant, and equipment?
- Ionis Pharmaceuticals (IONS) reported payments to acquire property, plant, and equipment of $21.76M in Q1 2026.
- How has Ionis Pharmaceuticals's payments to acquire property, plant, and equipment changed year-over-year?
- Ionis Pharmaceuticals's payments to acquire property, plant, and equipment increased by 73.0% year-over-year, from $12.58M to $21.76M.
- What is the long-term trend for Ionis Pharmaceuticals's payments to acquire property, plant, and equipment?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's payments to acquire property, plant, and equipment has grown at a 44.0% compound annual growth rate (CAGR), from $11.96M to $51.44M.
- What does payments to acquire property, plant, and equipment mean?
- Cash spent on long-term physical assets like buildings and machinery.
- How do you interpret payments to acquire property, plant, and equipment?
- Higher spending indicates investment in future capacity, while lower spending may suggest maintenance-only investment or capital efficiency.
- How does payments to acquire property, plant, and equipment compare across companies?
- A standard measure of capital intensity across all capital-intensive industries.